Third, limited by the lack of compliant proteomic datasets, we were only able to validate a small portion of our transcriptomic data – the transcriptomic data on CD4+ T cells from MS patients without treatment, and protein validation may continue in the future. Here, CD4 is linked to myeloid sarcoma.